In what appears to be an outpouring of benevolence, pharmaceutical companies have been falling over themselves to offer cheap vaccines to protect the world's poorest children from preventable diseases. But ifs not just goodwill: in the competition for contracts to supply UNICEF with childhood vaccines over the next five years, the emergence of new vaccine manufacturers has driven down prices.
展开▼